The origin of fibroblasts and mechanism of cardiac fibrosis

Journal of Cellular Physiology

Volumn 225, Issue 3, 2010, Pages 631-637

  Krenning, Guido ^a   Zeisberg, Elisabeth M ^a   Kalluri, Raghu ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL POPULATION; ENDOTHELIAL MESENCHYMAL TRANSITION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; HEART MUSCLE FIBROSIS; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANGIOGENESIS; ANIMAL; CELL LINEAGE; CELL TRANSDIFFERENTIATION; CORONARY BLOOD VESSEL; EXCITATION CONTRACTION COUPLING; FIBROSIS; HEART CONTRACTION; HEART DISEASE; HEART MUSCLE; HUMAN; METABOLISM; MORPHOGENESIS; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; CELL LINEAGE; CELL TRANSDIFFERENTIATION; CORONARY VESSELS; ENDOTHELIAL CELLS; EXCITATION CONTRACTION COUPLING; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBROSIS; HEART DISEASES; HUMANS; MORPHOGENESIS; MYOCARDIAL CONTRACTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 77957729712     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22322     Document Type: Review

References (104)

1. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. 2001. Peripheral blood fibrocytes: Differentiation pathway and migration to wound sites. J Immunol 166: 7556-7562.
2. Akpolat N, Yahsi S, Godekmerdan A, Yalniz M, Demirbag K. 2005. The value of alpha-SMA in the evaluation of hepatic fibrosis severity in hepatitis B infection and cirrhosis development: A histopathological and immunohistochemical study. Histopathology 47: 276-280.
3. Alva JA, Zovein AC, Monvoisin A, Murphy T, Salazar A, Harvey NL, Carmeliet P, Iruela-Arispe ML. 2006. VE-Cadherin-Cre-recombinase transgenic mouse: A tool for lineage analysis and gene deletion in endothelial cells. Dev Dyn 235: 759-767.
4. Anderson KR, Sutton MG, Lie JT. 1979. Histopathological types of cardiac fibrosis in myocardial disease. J Pathol 128: 79-85.
5. Arciniegas E, Neves CY, Carrillo LM, Zambrano EA, Rameirez R. 2005. endothelial-mesenchymal transition occurs during embryonic pulmonary artery development. Endothelium 12: 193-200.
6. Armstrong EJ, Bischoff J. 2004. Heart valve development: Endothelial cell signaling and differentiation. Circ Res 95: 459-470.
7. Azuma K, Ichimura K, Mita T, Nakayama S, Jin WL, Hirose T, Fujitani Y, Sumiyoshi K, Shimada K, Daida H, Sakai T, Mitsumata M, Kawamori R, Watada H. 2009. Presence of alpha-smooth muscle actin-positive endothelial cells in the luminal surface of adult aorta. Biochem Biophys Res Commun 380: 620-626.
8. Bagley RG, Honma N, Weber W, Boutin P, Rouleau C, Shankara S, Kataoka S, Ishida I, Roberts BL, Teicher BA. 2008. Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization. Microvasc Res 76: 180-188.
9. Banerjee I, Fuseler JW, Price RL, Borg TK, Baudino TA. 2007. Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am J Physiol Heart Circ Physiol 293: H1883-H1891.
10. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisen J. 2009. Evidence for cardiomyocyte renewal in humans. Science 324: 98-102.
11. Bosman FT, Stamenkovic I. 2003. Functional structure and composition of the extracellular matrix. J Pathol 200: 423-428.
12. Bowers SL, Banerjee I, Baudino TA. 2010. The extracellular matrix: At the center of it all. J Mol Cell Cardiol 48: 474-482.
13. Camelliti P, Borg TK, Kohl P. 2005. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res 65: 40-51.
14. Carver W, Terracio L, Borg TK. 1993. Expression and accumulation of interstitial collagen in the neonatal rat heart. Anat Rec 236: 511-520.
15. Chang HY, Chi JT, Dudoit S, Bondre C, van de RM, Botstein D, Brown PO. 2002. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA 99: 12877-12882.
16. Chaturvedi RR, Herron T, Simmons R, Shore D, Kumar P, Sethia B, Chua F, Vassiliadis E, Kentish JC. 2010. Passive stiffness of myocardium from congenital heart disease and implications for diastole. Circulation 121: 979-988.
17. Chilton L, Giles WR, Smith GL. 2007. Evidence of intercellular coupling between co-cultured adult rabbit ventricular myocytes and myofibroblasts. J Physiol 583: 225-236.
18. Chintalgattu V, Nair DM, Katwa LC. 2003. Cardiac myofibroblasts: A novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR. J Mol Cell Cardiol 35: 277-286.
19. Corda S, Samuel JL, Rappaport L. 2000. Extracellular matrix and growth factors during heart growth. Heart Fail Rev 5: 119-130.
20. Covas DT, Panepucci RA, Fontes AM, Silva WA, Jr., Orellana MD, Freitas MC, Neder L, Santos AR, Peres LC, Jamur MC, Zago MA. 2008. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp Hematol 36: 642-654.
21. de Bakker JM, van Capelle FJ, Janse MJ, Tasseron S, Vermeulen JT, de Jonge N, Lahpor JR. 1996. Fractionated electrograms in dilated cardiomyopathy: Origin and relation to abnormal conduction. J Am Coll Cardiol 27: 1071-1078.
22. de Lange FJ, Moorman AF, Anderson RH, Manner J, Soufan AT, de Gier-de VC, Schneider MD, Webb S, van den Hoff MJ, Christoffels VM. 2004. Lineage and morphogenetic analysis of the cardiac valves. Circ Res 95: 645-654.
23. Dezso K, Jelnes P, Laszlo V, Baghy K, Bodor C, Paku S, Tygstrup N, Bisgaard HC, Nagy P. 2007. Thy-1 is expressed in hepatic myofibroblasts and not oval cells in stem cell-mediated liver regeneration. Am J Pathol 171: 1529-1537.
24. Eghbali M, Weber KT. 1990. Collagen and the myocardium: Fibrillar structure, biosynthesis and degradation in relation to hypertrophy and its regression. Mol Cell Biochem 96: 1-14.
25. Engel FB, Schebesta M, Duong MT, Lu G, Ren S, Madwed JB, Jiang H, Wang Y, Keating MT. 2005. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev 19: 1175-1187.
26. Espira L, Czubryt MP. 2009. Emerging concepts in cardiac matrix biology. Can J Physiol Pharmacol 87: 996-1008.
27. Eyden B. 2001. The myofibroblast: An assessment of controversial issues and a definition useful in diagnosis and research. Ultrastruct Pathol 25: 39-50.
28. Franke WW, Schmid E, Osborn M, Weber K. 1979. Intermediate-sized filaments of human endothelial cells. J Cell Biol 81: 570-580.
29. Fredj S, Bescond J, Louault C, Potreau D. 2005. Interactions between cardiac cells enhance cardiomyocyte hypertrophy and increase fibroblast proliferation. J Cell Physiol 202: 891-899.
30. Fries KM, Blieden T, Looney RJ, Sempowski GD, Silvera MR, Willis RA, Phipps RP. 1994. Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin Immunol Immunopathol 72: 283-292.
31. Gaudesius G, Miragoli M, Thomas SP, Rohr S. 2003. Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin. Circ Res 93: 421-428.
32. Gittenberger-de Groot AC, Vrancken Peeters MP, Mentink MM, Gourdie RG, Poelmann RE. 1998. Epicardium-derived cells contribute a novel population to the myocardial wall and the atrioventricular cushions. Circ Res 82: 1043-1052.
33. Gray MO, Long CS, Kalinyak JE, Li HT, Karliner JS. 1998. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-Β1 and endothelin-1 from fibroblasts. Cardiovasc Res 40: 352-363.
34. Gurtner GC, Werner S, Barrandon Y, Longaker MT. 2008. Wound repair and regeneration. Nature 453: 314-321.
35. Hasenfuss G. 1998. Animal models of human cardiovascular disease, heart failure and hypertrophy. Cardiovasc Res 39: 60-76.
36. Haudek SB, Xia Y, Huebener P, Lee JM, Carlson S, Crawford JR, Pilling D, Gomer RH, Trial J, Frangogiannis NG, Entman ML. 2006. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci USA 103: 18284-18289.
37. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. 2007. The myofibroblast: One function, multiple origins. Am J Pathol 170: 1807-1816.
38. Hirano S, Suzuki ST, Redies C. 2003. The cadherin superfamily in neural development: Diversity, function and interaction with other molecules. Front Biosci 8: d306-d355.
39. Hu H, Sachs F. 1997. Stretch-activated ion channels in the heart. J Mol Cell Cardiol 29: 1511-1523.
40. Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV, Valerius MT, McMahon AP, Duffield JS. 2010. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176: 85-97.
41. Inoki I, Shiomi T, Hashimoto G, Enomoto H, Nakamura H, Makino Ki, Ikeda E, Takata S, Kobayashi Ki, Okada Y. 2002. Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J 16: 219-221.
42. Isenberg G, Kazanski V, Kondratev D, Gallitelli MF, Kiseleva I, Kamkin A. 2003. Differential effects of stretch and compression on membrane currents and [Na+]c in ventricular myocytes. Prog Biophys Mol Biol 82: 43-56.
43. Isoyama S, Nitta-Komatsubara Y. 2002. Acute and chronic adaptation to hemodynamic overload and ischemia in the aged heart. Heart Fail Rev 7: 63-69.
44. Jelaska A, Strehlow D, Korn JH. 1999. Fibroblast heterogeneity in physiological conditions and fibrotic disease. Springer Semin Immunopathol 21: 385-395.
45. Jiang ZS, Jeyaraman M, Wen GB, Fandrich RR, Dixon IMC, Cattini PA, Kardami E. 2007. High- but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1. J Mol Cell Cardiol 42: 222-233.
46. Kai H, Mori T, Tokuda K, Takayama N, Tahara N, Takemiya K, Kudo H, Sugi Y, Fukui D, Yasukawa H, Kuwahara F, Imaizumi T. 2006. Pressure overload-induced transient oxidative stress mediates perivascular inflammation and cardiac fibrosis through angiotensin II. Hypertens Res 29: 711-718.
47. Kamkin A, Kiseleva I, Isenberg G, Wagner KD, Gunther J, Theres H, Scholz H. 2003. Cardiac fibroblasts and the mechano-electric feedback mechanism in healthy and diseased hearts. Prog Biophys Mol Biol 82: 111-120.
48. Kania G, Blyszczuk P, Stein S, Valaperti A, Germano D, Dirnhofer S, Hunziker L, Matter CM, Eriksson U. 2009. Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis. Circ Res 105: 462-470.
49. Kaur H, Chaurasia SS, de Medeiros FW, Agrawal V, Salomao MQ, Singh N, Ambati BK, Wilson SE. 2009. Corneal stroma PDGF blockade and myofibroblast development. Exp Eye Res 88: 960-965.
50. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M. 2001. Tie2-Cre transgenic mice: A new model for endothelial cell-lineage analysis in vivo. Dev Biol 230: 230-242.
51. Kohl P. 2003. Heterogeneous cell coupling in the heart: An electrophysiological role for fibroblasts. Circ Res 93: 381-383.
52. Krenning G, Moonen JRAJ, van Luyn MJA, Harmsen MC. 2008. Vascular smooth muscle cells for use in vascular tissue engineering obtained by endothelial-to-mesenchymal transdifferentiation (EnMT) on collagen matrices. Biomaterials 29: 3703-3711.
53. Kuhn B, del Monte F, Hajjar RJ, Chang YS, Lebeche D, Arab S, Keating MT. 2007. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med 13: 962-969.
54. Langness U, Udenfriend S. 1974. Collagen biosynthesis in nonfibroblastic cell lines. Proc Natl Acad Sci USA 71: 50-51.
55. Li GR, Sun HY, Chen JB, Zhou Y, Tse HF, Lau CP. 2009. Characterization of multiple ion channels in cultured human cardiac fibroblasts. PLoS ONE 4: e7307.
56. Lie-Venema H, van den Akker NM, Bax NA, Winter EM, Maas S, Kekarainen T, Hoeben RC, DeRuiter MC, Poelmann RE, Gittenberger-de Groot AC. 2007. Origin, fate, and function of epicardium-derived cells (EPDCs) in normal and abnormal cardiac development. ScientificWorldJournal 7: 1777-1798.
57. Lindahl P, Johansson BR, Leveen P, Betsholtz C. 1997. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277: 242-245.
58. Liska DJ, Reed MJ, Sage EH, Bornstein P. 1994. Cell-specific expression of alpha 1(I) collagen-hGH minigenes in transgenic mice. J Cell Biol 125: 695-704.
59. Ljungqvist A, Unge G. 1973. The proliferative activity of the myocardial tissue in various forms of experimental cardiac hypertrophy. Acta Pathol Microbiol Scand A 81: 233-240.
60. Lucas JA, Zhang Y, Li P, Gong K, Miller AP, Hassan E, Hage F, Xing D, Wells B, Oparil S, Chen YF. 2010. Inhibition of transforming growth factor-beta signaling induces left ventricular dilation and dysfunction in the pressure-overloaded heart. Am J Physiol Heart Circ Physiol 298: H424-H432.
61. Lugus JJ, Park C, Ma YD, Choi K. 2009. Both primitive and definitive blood cells are derived from Flk-1+ mesoderm. Blood 113: 563-566.
62. MacFadyen JR, Haworth O, Roberston D, Hardie D, Webster MT, Morris HR, Panico M, Sutton-Smith M, Dell A, van der GP, Wienke D, Buckley CD, Isacke CM. 2005. Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium. FEBS Lett 579: 2569-2575.
63. Mandache E, Unge G, Appelgren LE, Ljungqvist A. 1973. The proliferative activity of the heart tissues in various forms of experimental cardiac hypertrophy studied by electron microscope autoradiography. Virchows Arch B Cell Pathol 12: 112-122.
64. Miragoli M, Gaudesius G, Rohr S. 2006. Electronic modulation of cardiac impulse conduction by myofibroblasts. Circ Res 98: 801-810.
65. Mohan RR, Mohan RR, Wilson SE. 2001. Discoidin domain receptor (DDR) 1 and 2: Collagen-activated tyrosine kinase receptors in the cornea. Exp Eye Res 72: 87-92.
66. Moonen JRAJ, Krenning G, Brinker MGL, Koerts JA, van Luyn MJA, Harmsen MC. 2010. Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny. Cardiovasc Res 86: 506-515.
67. Mork C, van Deurs B, Petersen OW. 1990. Regulation of vimentin expression in cultured human mammary epithelial cells. Differentiation 43: 146-156.
68. Munoz-Chapuli R, Perez-Pomares JM, Macias D, Garcia-Garrido L, Carmona R, Gonzalez-Iriarte M. 2001. The epicardium as a source of mesenchyme for the developing heart. Ital J Anat Embryol 106: 187-196.
69. Mussini E, Hutton JJ, Jr., Udenfriend S. 1967. Collagen proline hydroxylase in wound healing, granuloma formation, scurvy, and growth. Science 157: 927-929.
70. Niedermeier M, Reich B, Rodriguez GM, Denzel A, Schmidbauer K, Gobel N, Talke Y, Schweda F, Mack M. 2009. CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc Natl Acad Sci USA 106: 17892-17897.
71. Niessen K, Fu Y, Chang L, Hoodless PA, McFadden D, Karsan A. 2008. Slug is a direct Notch target required for initiation of cardiac cushion cellularization. J Cell Biol 182: 315-325.
72. Norris RA, Borg TK, Butcher JT, Baudino TA, Banerjee I, Markwald RR. 2008. Neonatal and adult cardiovascular pathophysiological remodeling and repair: Developmental role of periostin. Ann N Y Acad Sci 1123: 30-40.
73. Ogawa M, LaRue AC, Drake CJ. 2006. Hematopoietic origin of fibroblasts/myofibroblasts: Its pathophysiologic implications. Blood 108: 2893-2896.
74. Olaso E, Ikeda K, Eng FJ, Xu L, Wang LH, Lin HC, Friedman SL. 2001. DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. J Clin Invest 108: 1369-1378.
75. Olivey HE, Mundell NA, Austin AF, Barnett JV. 2006. Transforming growth factor-beta stimulates epithelial-mesenchymal transformation in the proepicardium. Dev Dyn 235: 50-59.
76. Ramirez-Montagut T, Blachere NE, Sviderskaya EV, Bennett DC, Rettig WJ, Garin-Chesa P, Houghton AN. 2004. FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor. Oncogene 23: 5435-5446.
77. Rettig WJ, Garin-Chesa P, Healey JH, Su SL, Ozer HL, Schwab M, Albino AP, Old LJ. 1993. Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin. Cancer Res 53: 3327-3335.
78. Risau W. 1997. Mechanisms of angiogenesis. Nature 386: 671-674.
79. Rohr S. 2004. Role of gap junctions in the propagation of the cardiac action potential. Cardiovasc Res 62: 309-322.
80. Sauk JJ, Nikitakis N, Siavash H. 2005. Hsp47 a novel collagen binding serpin chaperone, autoantigen and therapeutic target. Front Biosci 10: 107-118.
81. Shioshita K, Miyazaki M, Ozono Y, Abe K, Taura K, Harada T, Koji T, Taguchi T, Kohno S. 2000. Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis. Kidney Int 57: 619-631.
82. Smith TJ. 2004. Novel aspects of orbital fibroblast pathology. J Endocrinol Invest 27: 246-253.
83. Souders CA, Bowers SL, Baudino TA. 2009. Cardiac fibroblast: The renaissance cell. Circ Res 105: 1164-1176.
84. Spach MS, Boineau JP. 1997. Microfibrosis produces electrical load variations due to loss of side-to-side cell connections: A major mechanism of structural heart disease arrhythmias. Pacing Clin Electrophysiol 20: 397-413.
85. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, Neilson EG. 1995. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130: 393-405.
86. Sugimoto H, Mundel TM, Kieran MW, Kalluri R. 2006. Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther 5: 1640-1646.
87. Sundberg C, Ivarsson M, Gerdin B, Rubin K. 1996. Pericytes as collagen-producing cells in excessive dermal scarring. Lab Invest 74: 452-466.
88. Thedieck C, Kalbacher H, Kuczyk M, Muller GA, Muller CA, Klein G. 2007. Cadherin-9 is a novel cell surface marker for the heterogeneous pool of renal fibroblasts. PLoS ONE 2: e657.
89. Tsuruda T, Costello-Boerrigter LC, Burnett JC, Jr. 2004. Matrix metalloproteinases: Pathways of induction by bioactive molecules. Heart Fail Rev 9: 53-61.
90. van Amerongen MJ, Bou-Gharios G, Popa ER, van Ark J, Petersen AH, van Dam GM, van Luyn MJA, Harmsen MC. 2007a. Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction. J Pathol 214: 377-386.
91. van Amerongen MJ, Harmsen MC, van Rooijen N, Petersen AH, van Luyn MJA. 2007b. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am J Pathol 170: 818-829.
92. van Tuyn J, Atsma DE, Winter EM, van der Velde-van Dijke I, Pijnappels DA, Bax NA, Knaan-Shanzer S, Gittenberger-de Groot AC, Poelmann RE, van der Laarse L, van der Wall EE, Schalij MJ, de Vries AA. 2007. Epicardial cells of human adults can undergo an epithelial-to-mesenchymal transition and obtain characteristics of smooth muscle cells in vitro. Stem Cells 25: 271-278.
93. Villaschi S, Nicosia RF. 1994. Paracrine interactions between fibroblasts and endothelial cells in a serum-free coculture model. Modulation of angiogenesis and collagen gel contraction. Lab Invest 71: 291-299.
94. Vliegen HW, van der LA, Cornelisse CJ, Eulderink F. 1991. Myocardial changes in press ure overload-induced left ventricular hypertrophy. A study on tissue composition, polyploidization and multinucleation. Eur Heart J 12: 488-494.
95. Vogel WF, Abdulhussein R, Ford CE. 2006. Sensing extracellular matrix: An update on discoidin domain receptor function. Cell Signal 18: 1108-1116.
96. Wartiovaara J, Linder E, Ruoslahti E, Vaheri A. 1974. Distribution of fibroblast surface antigen: Association with fibrillar structures of normal cells and loss upon viral transformation. J Exp Med 140: 1522-1533.
97. Weber KT. 1989. Cardiac interstitium in health and disease: The fibrillar collagen network. J Am Coll Cardiol 13: 1637-1652.
98. Weber KT. 1997. Monitoring tissue repair and fibrosis from a distance. Circulation 96: 2488-2492.
99. Weber KT. 2000. Fibrosis and hypertensive heart disease. Curr Opin Cardiol 15: 264-272.
100. Wetzel A, Wetzig T, Haustein UF, Sticherling M, Anderegg U, Simon JC, Saalbach A. 2006. Increased neutrophil adherence in psoriasis: Role of the human endothelial cell receptor Thy-1 (CD90). J Invest Dermatol 126: 441-452.
101. Wynn TA. 2008. Cellular and molecular mechanisms of fibrosis. J Pathol 214: 199-210.
102. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R. 2007. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13: 952-961.
103. Zhao L, Eghbali-Webb M. 2001. Release of pro- and anti-angiogenic factors by human cardiac fibroblasts: Effects on DNA synthesis and protection under hypoxia in human endothelial cells. Biochim Biophys Acta 1538: 273-282.
104. Zhou B, von GA, Ma Q, Hu YW, Pu WT. 2010. Genetic fate mapping demonstrates contribution of epicardium-derived cells to the annulus fibrosis of the mammalian heart. Dev Biol 338: 251-261.